SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

13.88p
   
  • Change Today:
    -0.50p
  • 52 Week High: 26.10
  • 52 Week Low: 10.38
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 519,723
  • Market Cap: £35.91m
  • Beta: 0.01

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Key Personnel

CEO: Stuart Ashman
CFO: Manprit Singh Randhawa
Executive Director: Simon Hewitson
Group Finance Director: Emily Bertram
Independent Non-Executive Director: Catherine Denise Prescott
Non-Executive Chairman: Martin Braddock Hunt
Non-Executive Dir: Danielle Bekker

Contact Details

Address: The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF
Phone: +44 191 495 7325
Website: http://www.skinbiotherapeutics.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF33H870

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 13.88p
Change Today -0.50p
% Change -3.48 %
52 Week High 26.10
52 Week Low 10.38
Volume 519,723
Shares Issued 258.78m
Market Cap £35.91m
Beta 0.01

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.97% below the market average70.97% below the market average70.97% below the market average70.97% below the market average70.97% below the market average
76.19% below the sector average76.19% below the sector average76.19% below the sector average76.19% below the sector average76.19% below the sector average
Price Trend
42.6% below the market average42.6% below the market average42.6% below the market average42.6% below the market average42.6% below the market average
13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average
Income Not Available
Growth
50.12% above the market average50.12% above the market average50.12% above the market average50.12% above the market average50.12% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average

SBTX Dividends

No dividends found

Trades for 18-Aug-2025

Time Volume / Share Price
16:10 7,300 @ 13.82p
15:00 7,176 @ 13.94p
14:43 5,294 @ 13.94p
14:21 50,000 @ 13.95p
14:21 2,868 @ 13.95p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page